Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Quantification of Patient-Reported Adverse Events Following Trans-Rectal Ultrasound-Guided Intra-Prostatic Marker Insertion

NCT00923416 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT00923416
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00923416 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Quantification of Patient-Reported Adverse Events Following Trans-Rectal Ultrasound-Guided Intra-Prostatic Marker Insertion
Lead sponsor
University Health Network, Toronto
Phase
Observational
Overall status
Completed
Start date
September 30, 2008
Completion date
November 30, 2010
Enrollment
240 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer